Creabilis has expanded its senior management team. Alex Leech joins as vice president, head of finance and operations, James Sandy as senior vice president, head of development, and Peter Spargo as senior vice president of chemistry manufacturing and controls.

Leech was most recently head of operations at Solace Pharmaceuticals. Prior to Solace, Alex worked for the Pfizer R&D organization where he was head of European project management.

Sandy has over 25 years of pharmaceutical development R&D experience, most recently at Pfizer as development team leader of Pfizer's GI portfolio. He has held a number of senior management positions in the pharmaceutical sector.

Spargo has been involved in pharmaceutical research and development throughout an international career spanning over 22 years. He was most recently senior vice president of chemistry manufacturing and controls at Novexel.